Off-label use of pentazocine and the associated adverse events among pediatric surgical patients in a tertiary hospital in Northern Nigeria: a retrospective chart review
- 8 April 2019
- journal article
- review article
- Published by Taylor & Francis in Current Medical Research and Opinion
- Vol. 35 (9) , 1505-1512
Abstract
Background and aims: Pentazocine remains a widely used opioid pre-anesthetic medication and post-operative analgesic in low- and middle-income countries despite concerns. We assessed the adverse events (AEs) associated with off-label use of pentazocine in pediatric surgical patients and determined the possible risk factors associated with slow respiratory AEs. Method: Children ≤18 years old for surgery administered pentazocine IM/IV as a pre-anesthetic medication or post-operative analgesic. Pertinent data including total daily dose and duration of use of pentazocine and its associated AEs were obtained from patients’ case files. Risk factors associated with slow respiratory AEs were determined using logistic regression analyses. Results: 159 patients were included with median age of 2 years and mainly males (52.8%). Pentazocine was administered off-label to all patients for post-operative pain management (96.2%) or pre-anesthetic medication (3.8%). All patients experienced at least one AE with most experiencing 2-7 AEs. Rapid breathing (120; 18.7%), followed by fast pulse (101; 15.7%) and sleepiness/sedation/drowsiness (81; 12.6%) were the most common AEs. None of the demographics and clinical variables significantly predicted the risk of slow respiratory AEs. Conclusion: Off-label use of pentazocine is common and associated with multiple AEs. Care is needed as no predictors of slow respiratory AEs were observed.Keywords
This publication has 37 references indexed in Scilit:
- Preventing Opioid-Related Deaths in Children Undergoing SurgeryPain Medicine, 2012
- Using text‐mining techniques in electronic patient records to identify ADRs from medicine useBritish Journal of Clinical Pharmacology, 2012
- Calcific myofibrosis due to pentazocine abuse: a case reportJournal of Medical Case Reports, 2008
- Adverse drug reactions and off‐label prescribing for paediatric outpatients: a one‐year survey of spontaneous reports in SwedenPharmacoepidemiology and Drug Safety, 2003
- Diagnostic value of tachypnoea in pneumonia defined radiologicallyArchives of Disease in Childhood, 2000
- Comparison of the calming and sedative effects of nalbuphine and pentazocine for paediatric premedicationCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1980
- Skin manifestations of pentazocine abuseJournal of the American Academy of Dermatology, 1980
- Pentazocine (Fortral) as postoperative analgesic in children.Archives of Disease in Childhood, 1974
- Toxic epidermal necrolysis associated with pentazocine therapy and severe reversible renal failureBritish Journal of Dermatology, 1973
- A Comparison of Pentazocine with Morphine in Premedication for Adenotonsillectomy in ChildrenAnz Journal of Surgery, 1971